Shareholders at AIM ImmunoTech (NYSE: AIM) approve >19.99% issuances and reverse split
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
AIM ImmunoTech Inc. held a Special Meeting of Stockholders on July 15, 2026, with 10,671,690 of 27,724,245 common shares represented, or 38.5%, exceeding the 33 and 1/3% quorum requirement. Stockholders approved several proposals tied to future equity issuance and capital structure flexibility.
They authorized, for NYSE American Company Guide Sections 713(a) and 713(b) compliance, the issuance of more than 19.99% of outstanding common stock upon exercise of Class H, Class I and Class J common stock purchase warrants, and upon conversion or other satisfaction of promissory notes dated February 16, 2024 and November 18, 2025. Stockholders also approved amendments permitting the Board, at its option, to implement a reverse stock split at a ratio of up to 1-for-25, and approved the ability to adjourn the Special Meeting to a later date or time to solicit additional proxies if necessary.
Positive
- None.
Negative
- Potential significant dilution: Multiple approvals permit issuing more than 19.99% of outstanding common stock upon exercise of Class H, I and J warrants and conversion or satisfaction of two promissory notes, increasing authorized issuances relative to the current share base.
- Reverse stock split authorization: Stockholders approved amendments allowing the Board to implement a reverse stock split of up to 1-for-25, a substantial change to the company’s common stock structure if the Board chooses to effect it.
8-K Event Classification
Item 5.07 — Submission of Matters to a Vote of Security Holders
1 item
Item 5.07
Submission of Matters to a Vote of Security Holders
Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Key Figures
Shares outstanding: 27,724,245 shares
Shares represented: 10,671,690 shares
Quorum threshold: 33 and 1/3%
+3 more
6 metrics
Shares outstanding
27,724,245 shares
Common stock outstanding and entitled to vote as of the Special Meeting record date
Shares represented
10,671,690 shares
Shares present in person or by proxy at the Special Meeting, 38.5% of outstanding
Quorum threshold
33 and 1/3%
Minimum percentage of shares required for Special Meeting quorum
Issuance limit trigger
more than 19.99% of outstanding common stock
Maximum issuance level approved for warrants and promissory notes under NYSE American Sections 713(a) and 713(b)
Reverse split ratio
up to 1-for-25
Maximum reverse stock split ratio authorized at the Board’s discretion
Proposal 6 For votes
7,344,727 shares
Shares voting for the reverse stock split authorization proposal
Key Terms
NYSE American Company Guide Sections 713(a) and 713(b), Class H common stock purchase warrants, reverse stock split, Broker Non-Votes, +2 more
6 terms
NYSE American Company Guide Sections 713(a) and 713(b) regulatory
"for purposes of complying with NYSE American Company Guide Sections 713(a) and 713(b)"
Class H common stock purchase warrants financial
"upon the exercise of the Class H common stock purchase warrants"
reverse stock split financial
"to effect, at the option of our Board of Directors, a reverse stock split of our outstanding common stock"
A reverse stock split reduces a company's number of outstanding shares while raising the price per share proportionally, so the total value of each investor's holding is unchanged; a 1-for-10 split turns 100 shares worth $1 each into 10 shares worth $10 each. Companies often do this to regain compliance with an exchange's minimum price rule or to attract investors who avoid very low-priced stocks.
Broker Non-Votes financial
"For: | | Against: | | Abstain: | | Broker Non-Votes 2,677,035"
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.
warrant exercise inducement offer letter agreement financial
"pursuant to the warrant exercise inducement offer letter agreement dated May 7, 2026"
promissory note financial
"upon the conversion or other satisfaction of that certain promissory note dated February 16, 2024"
A promissory note is a written IOU in which one party promises to pay a specific sum, often with interest, to another party by a set date or on demand. Investors care because it functions like a loan: it creates a legal claim on future cash flows, carries credit and timing risk, and can affect valuation or liquidity—think of it as a formal, tradable promise to be repaid that can be assessed like any other debt investment.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did AIM ImmunoTech (AIM) approve at the July 15, 2026 Special Meeting?
AIM ImmunoTech stockholders approved several proposals enabling larger share issuances and capital structure changes. Approvals cover issuing more than 19.99% of outstanding stock for specified warrants and promissory notes, authorizing a reverse stock split up to 1-for-25, and permitting adjournment to solicit additional proxies.
What reverse stock split did AIM ImmunoTech (AIM) authorize?
Stockholders approved alternate amendments to AIM’s Certificate of Incorporation enabling the Board, at its option, to implement a reverse stock split at a ratio of up to 1-for-25. The exact ratio and timing, if any, are left to the Board’s sole discretion.
What were the voting results on AIM ImmunoTech (AIM) reverse split Proposal 6?
For Proposal 6, which authorized a reverse stock split up to 1-for-25, stockholders cast 7,344,727 shares for, 3,315,347 against, and 11,616 abstaining, with no broker non-votes reported. Based on these results, the reverse split authorization was approved.
Why did AIM ImmunoTech (AIM) seek approval to adjourn the Special Meeting?
Proposal 7 asked stockholders to approve possible adjournment of the Special Meeting to a later date or time. This would permit further solicitation of proxies if votes were insufficient to approve other proposals. Stockholders approved this adjournment authority with 7,380,255 for and 2,938,798 against.